News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
Partners

Andrea Eleazar, MHS

Articles by Andrea Eleazar, MHS

Graphic of the gastric system

Durvalumab/FLOT Boosts OS in Resectable Gastric Cancer

ByAndrea Eleazar, MHS

November 7th 2025

Durvalumab plus FLOT chemotherapy improved overall survival in resectable gastric or gastroesophageal junction cancer, per phase 3 MATTERHORN data.

Latest Updated Articles

Trending on Oncology Nursing News

FDA Approves Subcutaneous Daratumumab in High-Risk Smoldering Myeloma

Frontline Vaccine/Pembro Yields PFS Benefit in Advanced Melanoma

Durvalumab/FLOT Boosts OS in Resectable Gastric Cancer

APP-Led Quality Assurance Group Is Feasible, Identifies Safety Events

© 2025 MJH Life Sciences^®

All rights reserved.